MedGenome

MedGenome MedGenome is a leading provider of molecular diagnostics solutions to hospitals and clinicians.

MedGenome is a leading provider of molecular diagnostics solutions to hospitals and clinicians, enabling personalized healthcare. Its innovative offerings in molecular diagnostics apply advanced software and bioinformatics tools to curated omics data, combined with MedGenome’s proprietary knowledge base and powerful analytics. MedGenome’s genomics bioinformatics platform is available to global pharmaceuticals, research and diagnostics organizations. MedGenome has pioneered Whole Genome, Whole Exome and Multi-Gene Panel disease panel based diagnostics in India. MedGenome genomic products and services will empower doctors and patients in matters of health and disease management by providing them with relevant genetic information. MedGenome has developed many single gene tests, disease panels and investigational tests covering Oncology, Pediatrics, Prenatal, Cardiology, Ophthalmology, Neurology, and other specialties. Our OncoMD Cancer Analytics Platform curates and validates genomics and proteomics data captured from leading peer reviewed scientific journals and other relevant data sources. The platform combines curated data with software bioinformatics and powerful analytics to deliver actionable information for clinical diagnosis and treatment decisions. MedGenome also partners with clients on genomic based exploratory research and drug discovery. Our ability to leverage existing longitudinal studies, design population studies from scratch and also conduct follow up studies on cohorts provides valuable benefits to our global research partners

MedGenome was incubated for 2 years as a division of SciGenom Labs, Cochin, India. It was spun off as a separate company with headquarters in Narayana Health City, Bangalore in 2013. MedGenome at Narayana Nethralaya (NN) has a co-located lab spanning over 10,000 sq.ft of lab space at Narayana Nethralaya. MedGenome has a multi faceted team spread across the country, facilitating its pan India operations.

Featured on The Times Of India for  Read now: https://timesofindia.indiatimes.com/life-style/health-fitness/health-news/...
20/11/2025

Featured on The Times Of India for

Read now: https://timesofindia.indiatimes.com/life-style/health-fitness/health-news/diabetes-how-understanding-your-genetics-can-help-prevent-complications/articleshow/125304304.cms

Dr. Ramesh Menon, Director of Personal Genomics and Genomic Medicine, MedGenome, talks about how genetics shapes the risk, onset, and severity of diabetic complications.

While diabetes is commonly viewed through the lens of blood sugar control, Dr. Menon highlights that genetic variations can influence how the disease can lead to complications such as retinopathy, nephropathy, neuropathy, and cardiovascular diseases, even among individuals managing their diabetes well. Genetic testing can empower us to comprehensively understand our condition and effectively prevent and manage diabetes and its complications.

If you have a family history of any health conditions, talk to your clinician to learn more about genetic tests and ensure healthier futures for you and your loved ones. You can also reach out to our genetic counsellors at https://diagnostics.medgenome.com/medgenome-genetic-counseling/

Can healthy habits outrun your genetic diabetes risk?Take a quick poll and tell us what you think.
18/11/2025

Can healthy habits outrun your genetic diabetes risk?

Take a quick poll and tell us what you think.

Join Dr. Vedam Ramprasad, CEO of MedGenome, on India Today TV Health 360 today!As he discusses the role of genomics in c...
15/11/2025

Join Dr. Vedam Ramprasad, CEO of MedGenome, on India Today TV Health 360 today!

As he discusses the role of genomics in cancer diagnosis and treatment, and how it is transforming cancer care in the country, with Sneha Mordani.

Watch it live at 3:30 PM: https://www.indiatoday.in/livetv

14/11/2025

This World Diabetes Day, Dr Subramanian Kannan, Consultant Endocrinologist at Narayana Health Bangalore, shares an important message. Many people in India are now getting diabetes at a young age and the reasons can differ from person to person.

Some may have type 1 diabetes, some may have early type 2 diabetes, which could be a multi-gene or polygenic condition, or it could be monogenic or single gene related. In certain people, genetic testing can help doctors confirm monogenic diabetes. This is useful because some of these patients respond very well to targeted medicines.

Genetic testing can also help doctors plan treatment during pregnancy and understand the risk for children or other family members.

Diabetes is not the same for everyone. Knowing the correct type can make treatment safer and more effective.

Can your genes warn you before type 2 diabetes shows up? Take a quick poll and tell us what you think.
13/11/2025

Can your genes warn you before type 2 diabetes shows up?
Take a quick poll and tell us what you think.

Featured on The Times of IndiaRead more: https://timesofindia.indiatimes.com/life-style/health-fitness/health-news/how-g...
08/11/2025

Featured on The Times of India
Read more: https://timesofindia.indiatimes.com/life-style/health-fitness/health-news/how-genes-influence-the-risk-of-age-related-blindness/articleshow/125064996.cms

Dr. N. Soumittra, Disease Head, Ophthalmology, MedGenome, explains how specific gene variants can significantly influence an individual’s risk of developing age-related macular degeneration (AMD), which is one of the leading causes of vision loss in older adults.

She highlights how advancements in genetic testing are enabling targeted preventive strategies and timely clinical intervention to slow or mitigate disease progression.

A single test with deepest answers- Introducing TumorTrack Advance: MedGenome’s most comprehensive cancer test that help...
07/11/2025

A single test with deepest answers- Introducing TumorTrack Advance: MedGenome’s most comprehensive cancer test that helps doctors find the right treatment faster. It detects key genetic changes across 500+ cancer-related genes, giving patients and families clearer direction, more time, and renewed hope.

To know more, 1800-296-9696 | diagnostics@medgenome.com

05/11/2025

We are delighted to share that MedGenome has made a majority investment in Green Cross Genetics Lab, Gujarat's leading diagnostic chain.

Through this partnership, we are not only expanding our genomics offerings in Western India, but we are now also uniquely positioned to provide a broader range of services to our physicians and patients, empowering them with a comprehensive portfolio of diagnostics and enabling faster and more accurate health insights.

We’re excited about the road ahead and will continue to make genomics affordable, accessible, and equitable across the country.

For decades, traditional karyotyping has been a standard method for identifying major chromosomal changes.KaryoSeq Low P...
04/11/2025

For decades, traditional karyotyping has been a standard method for identifying major chromosomal changes.

KaryoSeq Low Pass Whole Genome Sequencing builds on this approach by sequencing the entire genome, offering a broader and more detailed view that includes both large-scale and smaller chromosomal variations.

It provides additional genomic information that can support more informed clinical decisions.

To know more, read our blog: https://diagnostics.medgenome.com/blog/karyoseq-low-pass-whole-genome-sequencing-vs-traditional-karyotyping/

02/11/2025

From NGS based Tests to BioFire Panels, MedGenome offers a comprehensive suite of Infectious Disease Tests.
Our precision diagnostics enable faster, accurate pathogen detection, guiding timely, targeted treatment and improving outcomes.

To know more, diagnostics@medgenome.com | 1800 296 9696

“Over the past four years at MedGenome, including the last 1.5 years as a lead, I've grown significantly on a profession...
31/10/2025

“Over the past four years at MedGenome, including the last 1.5 years as a lead, I've grown significantly on a professional level. The experiences and lessons I've gained here are ones I will carry with me throughout my career. I firmly believe that there will never be a point where I can say, "I've learned enough" when it comes to science. Throughout my time here, I've had the opportunity to work with some of the best minds, gaining invaluable knowledge and applying it in meaningful ways. MedGenome is a place that truly values your efforts, supports your interests, and encourages growth every step of the way.

Choosing a path less traveled already sets the stage for making a difference. In recent years, genetic diagnostics has gained significant attention, with more clinicians now incorporating genetic testing into routine investigations. This shift plays a crucial role in patient management and future planning. As someone who regularly interacts with both clinicians for result interpretation and the lab team for test ex*****on, I see firsthand how our knowledge and expertise directly contribute to improving clinical care.”

- Divya Ramani

Address

MedGenome Labs Ltd. Ground Floor, Tower 1, E-City Software Park, Electronic City – Phase 1
Bangalore
560100

Opening Hours

Monday 9am - 6pm
Tuesday 9am - 6pm
Wednesday 9am - 6pm
Thursday 9am - 6pm
Friday 9am - 6pm

Telephone

+9118001033691

Alerts

Be the first to know and let us send you an email when MedGenome posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to MedGenome:

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Category